Perspectives

Face-to-face meetings are essential for elite financiers and a global survey strongly suggests travel time should be no more than a 15- to 20-minute walk or taxi ride, writes the Olin School’s David Meyer.

Ian Clark, a doctoral candidate in English in Arts & Sciences, writes about the show “Derry Girls” and its handling of Irish history on the “Human Ties” blog.

Markus Baer, a professor of organizational behavior at Olin Business School, writes an article about how business leaders can guide their companies through times of uncertainty, saying that adaptability is key for businesses large and small.

In this episode of the “Show Me the Science” podcast, learn about efforts in St. Louis and Kenya to identify and treat young people at risk for schizophrenia and other serious conditions. The international study’s goal is to improve early diagnosis and treatment.

Genevra Sforza (ca. 1441-1507) lived her long life near the apex of Italian Renaissance society, as wife of two successive de facto rulers of Bologna. A new book by Elizabeth Bernhardt in Arts & Sciences explores both her life story and misogynistic legends about the supposed destruction of Bologna and the Bentivoglio family.

The Nazi context differed significantly from Renaissance Italy’s: There were no negotiations or exceptions, not even for large payments. But the mockery by children, the loss of status, and the shame remained, writes Flora Cassen.

In an opinion piece, James Wertsch, the David R. Francis Distinguished Professor and an expert on Russia, discusses Vladimir Putin’s incessant use of false national narratives to justify its invasion of Ukraine.

Tabea Linhard, a professor in Arts & Sciences, writes on the “Human Ties” blog about her experience, thanks to a cross-training grant from the Center for the Humanities, exploring a new discipline to better understand and support the migrants with whom she works.

If a judge can remove mifepristone from the market with such little notice, all drugs are vulnerable — those on the shelf, and those yet to be, writes Rachel Sachs in The Washington Post.

A working group led by Jorge Llibre-Guerra, MD, at the School of Medicine, published a perspective piece arguing for including more people from low and middle-income countries in Alzheimer’s clinical trials. “Democratization of clinical trials will ensure that potential treatments are safe, effective, accessible and equitable,” they wrote.